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Background and purpose: Decision making (DM) has been defined as the process through which a 
person forms preferences, selects and executes actions, and evaluates the outcome related to a selected 
choice. This ability represents an important factor for adequate behaviour in everyday life. DM impairment 
in multiple sclerosis (MS) has been previously reported. The purpose of the present study was to assess 
DM in patients with MS at the earliest clinically detectable time point of the disease. 
 
Methods: Patients with definite (n=109) or possible (clinically isolated syndrome, CIS; n=56) MS, a short 
disease duration (mean 2.3 years) and a minor neurological disability (mean EDSS 1.8) were compared to 
50 healthy controls aged 18 to 60 years (mean age 32.2) using the Iowa Gambling Task (IGT). Subjects 
had to select a card from any of 4 decks (A/B [disadvantageous]; C/D [advantageous]). The game 
consisted of 100 trials then grouped in blocks of 20 cards for data analysis. Skill in DM was assessed by 
means of a learning index (LI) defined as the difference between the averaged last three block indexes and 
first two block indexes (LI=[(BI-3+BI-4+BI-5)/3-(BI-1+B2)/2]). Non parametric tests were used for statistical 
analysis. 
 
Results: LI was higher in the control group (0.24, SD 0.44) than in the MS group (0.21, SD 0.38), however 
without reaching statistical significance (p=0.7). Interesting differences were detected when MS patients 
were grouped according to phenotype. A trend to a difference between MS subgroups and controls was 
observed for LI (p=0.06), which became significant between MS subgroups (p=0.03).  CIS patients who 
confirmed MS diagnosis by presenting a second relapse after study entry showed a dysfunction in the IGT 
in comparison to the other CIS (p=0.01) and definite MS (p=0.04) patients. In the opposite, CIS patients 
characterised by not entirely fulfilled McDonald criteria at inclusion and absence of relapse during the study 
showed an normal learning pattern on the IGT. Finally, comparing MS patients who developed relapses 
after study entry, those who remained clinically stable and controls, we observed impaired performances 
only in relapsing patients in comparison to stable patients (p=0.008) and controls (p=0.03). 
 
Discussion: These results raise the assumption of a sustained role for both MS relapsing activity and 
disease heterogeneity (i.e. infra-clinical severity or activity of MS) in the impaired process of decision 
making.  
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CHUV RESEARCH DAY 2008 
Thursday, January 17th, 2008 
“Regenerative Medicine” 
 
 
 
08:30 Presentation of the 2008 Research Day 
Professor Ivan Stamenkovic, Vice Dean for Research  
    
08:45 Keynote 
speaker 1 
 
 
 
Professor Philippe Menasché 
Department of Cardio-Vascular Surgery 
Hôpital Européen G. Pompidou, Paris 
“Promises and pitfalls of skeletal myoblast therapy” 
    
09:30 Coffee & Posters   
    
10:30 6 short talks   
    
12:00 Keynote 
speaker 2 
 
 
Professor Giulio Cossu 
Stem Cell Research Institute, Milano 
“Towards a cell therapy for muscular dystrophy” 
    
12:45 Lunch, Coffee & Posters  
    
14:00 Keynote 
speaker 3 
 
Professor Michele De Luca 
Department of Biomedical Sciences, Modena 
Epithelial Stem Cell Research Centre, Venice 
“Epithelial stem cells and regenerative medicine” 
    
14:45 6 short talks   
    
16:15 Coffee & Posters  
    
17:00 Keynote 
speaker 4 
 
Professor Lior Gepstein 
Dept of Physiology & Biophysics, Technion – Haifa, 
Israel 
“Myocardial Regeneration by Human Embryonic 
Stem Cells” 
    
17:45 Poster Prizes Ceremony  
    
18:00 Apéritif & Buffet  
 
ATTENDANCE IS FREE - NO REGISTRATION IS NECESSARY 
   
NOTE: Posters will be displayed from  
Wednesday January 16st early morning  to Friday January 18th  early morning. 
 
 
  
 
 
 
 
12 short talks 
 
 
Schedule 
 
 
Names, departments 
 
 
Titles 
 
 
Morning 
 
10h30 - 10h45 Boris Hinz 
Laboratoire de biophysique 
cellulaire - EPFL 
“The myofibroblast - friend and foe in tissue 
regeneration” 
10h45 – 11h00 Matthias Lutolf  
Laboratoire de cellules souches et 
bioengineering - EPFL 
 
"Bioengineering artificial stem cell niches".  
11h00 – 11h15 Corinne Kostic 
Unité de thérapie génique et 
biologie des cellules souches – 
Hôpital Ophtalmique 
"Gene therapy preclinical studies for Leber 
congenital amaurosis" 
 
11h15 – 11h30 Anne Zurn 
Chirurgie expérimentale - CHUV 
“Delayed peripheral nerve priming improves 
regeneration of sensory axons 
into the spinal cord following dorsal root 
injury.” 
 
11h30 – 11h45 Meta Djojosubroto  
Unité de thérapie génique et 
biologie des cellules souches – 
Hôpital Ophtalmique 
“Increased chromosomal aberrations and 
transformation of adult mouse retinal stem 
cells” 
11h45 – 12h00 Paola Bonfanti 
Chirurgie expérimentale - CHUV & 
Laboratoire de dynamique des 
cellules souches - EPFL 
 
“Thymic epithelial cells have skin potency” 
 
Afternoon 
 
14h45 – 15h00 Dominique Pioletti 
Laboratoire de biomécanique en 
orthopédie - EPFL 
“In Vivo evaluation of human fetal cells as 
allogenic cell source for tissue engineering” 
 
15h00 – 15h15 Mikaël Martino 
Laboratoire de médecine 
régénérative et de 
pharmacobiologie - EPFL 
“Controlling mesenchymal stem cells response 
to biomaterials with recombinant integrin-
specific fibronectin fragments” 
 
15h15 – 15h30 Dela Golshayan 
Nephrologie et Centre de 
Transplantation d’organes - CHUV 
 
“Mechanisms of Allograft rejection and 
tolerance in transplantation” 
 
15h30 - 15h45 Jonathan Bloch 
Médecine Interne - CHUV 
"Spleen derived vascular progenitor cell 
transfer restores metabolic and vascular 
insulin sensitivity in high-fat diet insulin 
resistant mice" 
 
15h45 - 16h00 Marc-Etienne Roehrich 
Cardiologie – CHUV  
“Immunophenotypical analysis of putative 
cardiac progenitor cells isolated 
based on high ALDH activity from adult 
mouse and human hearts” 
 
16h00 – 16h15 Mohamed Nemir 
Dpt de Médecine - CHUV 
"Control of cardiac integrity via the Notch1 
receptor pathway". 
 
